Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fundraising and Appointment o

1 Aug 2008 07:00

RNS Number : 4124A
Oxford Advanced Surfaces Group PLC
01 August 2008
 

1 August 2008

Oxford Advanced Surfaces Group plc

Fundraising and appointment of Broker

Oxford Advanced Surfaces Group plc ("OASG" or the "Company") which develops and commercialises advanced materials and technology solutions leveraging breakthrough surface modification technology, announces that it has successfully completed a fundraising of £5 million (before expenses) with a number of new and existing shareholders (the "Fundraising"). The Company also announces the appointment of Novum Securities Limited ("Novum") as broker to the Company.

The Fundraising

The Company has today entered into a placing agreement with Novum under the terms of which Novum has agreed, as agent for the Company, to use reasonable endeavours to procure placees for 7,311,000 new ordinary shares ("the Placing Shares") at the placing price of 65p per new share ("the Placing").

Simultaneously with and conditional on completion of the Placing, the following directors of the Company have agreed to subscribe in aggregate for 384,600 new ordinary shares, representing per cent. of the Fundraising and an aggregate subscription amount of £249,990: 

Director

No. of new ordinary shares subscribed

Amount

Marcelo Bravo

38,500

£25,025

Philip Spinks

11,500

£7,475

David Norwood

307,700

£200,005

Jeremy Scudamore

15,400

£10,010

Andrew Naylor

11,500

£7,475

Application has been made for the 7,695,600 new ordinary shares to be admitted to trading on AIM ("Admission") which is expected to take place on 6th August 2008. Completion of the Fundraising is conditional upon Admission.

The new ordinary shares to be issued pursuant to the Fundraising represent approximately 4% of the current issued share capital. Once issued, the total voting rights of the company will be 185,619,038 ordinary shares.

Information on OASG

OASG develops and commercialises advanced materials and technology solutions leveraging a proprietary surface modification technology called Onto. The technology exploits and controls a reactive chemistry allowing the rapid and convenient modification of the surface properties of a wide range of materials with a high degree of control over processing parameters. Onto can be applied as a wet coating by spin, dip, roll or spray and cured with either heat or irradiation. By selective coating (screen, inkjet printing) or selective curing (photolithography) highly patterned surfaces can be formed. This delivers valuable changes to surface functionality. The Onto™ coating technology is a versatile, effective, yet simple approach to deliver intelligent advanced materials.

Reasons for the Fundraising

Since joining AIM in December 2007OASG has made significant progress in developing its proprietary science towards commercial applications. The Company is in negotiations with a number of major companies in the UK, Europe and the USA with regards to a diverse range of applications for its core patented technology Onto.  In addition to a joint development agreement with DuPont Advanced Fibre Systems, the Company has entered into 5 other agreements with companies offering significant opportunity. The net result is that the Company currently has 8 projects in the development phase across a broad range of commercial applications and a significant number of other opportunities awaiting proof of concept.

Whilst the business has adequate resources to continue to implement its original business plan and service this ongoing programme, there is substantial demand for the Company's technology which the Company is currently unable to meet. The additional capital raised by the Fundraising will enable the Company to expand the number of projects it undertakes thereby meeting the existing demand for its services.

Outlook

The increasing need for innovation, cost reduction and kinder environmental processes continues to underpin the growing demand for advanced materials. Onto™ is a platform technology that is applicable across a range of applications whilst leveraging a well defined chemical process. This is evidenced in the demand the Company has received which varies from applications in household goods to mass produced electronics products to large-scale industrial manufacturing.

Over the next 18 months the Company has a pipeline of projects and development agreements to undertake and progress with a view to achieving commercial revenues. Whilst not all of these projects will progress through the development pipeline they are each revenue opportunities that have arisen out of a genuine customer need. The completion of the Fundraising brings an increased ability to capitalise on this demand and therefore the outlook for the Company is extremely encouraging.

Marcelo Bravo, Chief Executive commented:

"We are delighted to have been able to raise this additional finance in difficult market conditions, underlining the strength of our technology and business plan. The Fundraising will enable us to take full advantage of the opportunities that are available to us and accelerate the scale up of our business."

Enquiries:

Oxford Advanced Surfaces Group plc

Marcelo Bravo, Chief Executive

Tel: 01865 845807

Novum Securities Limited - Broker

Henry Turcan

Michael Brennan

Tel: 020 7562 4700

Zimmerman Adams International  - Nominated Adviser

Ray Zimmerman/Jonathan Evans

Tel: 020 7398 2900

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBRGDRDUXGGIB
Date   Source Headline
5th Jan 20237:00 amRNSCancellation - DEEPMATTER GROUP PLC
4th Jan 20238:00 amRNSHolding(s) in Company
29th Dec 20225:30 pmRNSDeepmatter Group
20th Dec 20227:00 amRNSHolding(s) in Company
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
19th Dec 20223:44 pmRNSResult of General Meeting
19th Dec 20222:05 pmRNSSecond Price Monitoring Extn
19th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 202211:05 amRNSSecond Price Monitoring Extn
19th Dec 202211:00 amRNSPrice Monitoring Extension
15th Dec 20224:40 pmRNSSecond Price Monitoring Extn
15th Dec 20224:35 pmRNSPrice Monitoring Extension
15th Dec 20222:05 pmRNSSecond Price Monitoring Extn
15th Dec 20222:00 pmRNSPrice Monitoring Extension
9th Dec 202211:05 amRNSSecond Price Monitoring Extn
9th Dec 202211:00 amRNSPrice Monitoring Extension
8th Dec 20228:46 amRNSHolding(s) in Company
2nd Dec 20227:00 amRNSPosting of Circular
1st Dec 20227:00 amRNSProposed Cancellation of Ordinary Shares
24th Nov 20227:00 amRNSCorporate Update
31st Oct 202212:00 pmRNSDirector/PDMR Shareholding
26th Oct 20227:00 amRNSTrading Update
26th Oct 20227:00 amRNSDeepMatter signs multi-year license agreement
26th Aug 20221:25 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSHalf Year Results
28th Jun 20227:00 amRNSDeepMatter acquires AI specialist ChemIntelligence
20th Jun 20224:41 pmRNSSecond Price Monitoring Extn
20th Jun 20224:35 pmRNSPrice Monitoring Extension
20th Jun 20222:05 pmRNSSecond Price Monitoring Extn
20th Jun 20222:00 pmRNSPrice Monitoring Extension
20th Jun 202211:05 amRNSSecond Price Monitoring Extn
20th Jun 202211:00 amRNSPrice Monitoring Extension
9th Jun 20225:26 pmRNSHolding(s) in Company
27th May 20222:30 pmRNSResult of AGM
25th May 20222:30 pmRNSIssue of Equity and TVR
23rd May 20227:00 amRNSDirectorate Change
20th May 20227:00 amRNSContract extension
11th May 20227:00 amRNSContract
27th Apr 20227:00 amRNSFinal Results
30th Mar 20224:00 pmRNSHolding(s) in Company
1st Mar 20227:00 amRNSContract
14th Feb 20227:00 amRNSDirector/PDMR Shareholding
26th Jan 20223:20 pmRNSHolding(s) in Company
26th Jan 20223:15 pmRNSHolding(s) in Company
26th Jan 20227:00 amRNSHolding(s) in Company
25th Jan 20225:45 pmRNSHolding(s) in Company
25th Jan 202212:30 pmRNSHolding(s) in Company
25th Jan 20227:00 amRNSDirector/PDMR Shareholding
25th Jan 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.